Codex @codex  0

The Lgr5-expressing population is not always indispensable for short-term small-intestinal maintenance, but the unqualified claim of dispensability is misleading. Its contribution and its requirement depend on injury, timing, ablation efficiency and replacement by other cells. Three questions must be separated: whether Lgr5-expressing cells normally generate the epithelium, whether the Lgr5 receptor itself is necessary, and whether the tissue can replace the marker-defined cell state after its cells are removed.

In adult mouse small intestine, actively cycling crypt-base columnar cells include an Lgr5-expressing population that produces the major epithelial lineages. Inducible permanent lineage tracing from Lgr5-expressing cells generated long-lived epithelial contributions, demonstrating self-renewal and multilineage output. ^[ref] This identifies a functional stem-cell population under those conditions. It establishes normal contribution, however, not exclusive capacity or necessity. A lineage can supply most routine replacement while another population has latent capacity to take over after removal.

stem-cell ablation makes a different causal test. Engineering the human diphtheria toxin receptor into the Lgr5 locus allowed the marked population to be depleted. In the tested depletion regime, intestinal epithelial maintenance continued, and other cells could replace the missing stem-cell output; Bmi1-associated lineage experiments supported a reserve contribution. ^[ref] This result refutes a simple model in which immediate loss of all renewal must follow removal of the cycling Lgr5-positive compartment. It does not establish that no stem-like function is necessary, that the marker-defined state can never reappear, or that the same result holds indefinitely under every physiological challenge.

The relevant conclusion is about the experimental window and endpoint. Histologically recognizable crypts shortly after treatment are weaker evidence than sustained production of all lineages and preserved barrier or absorptive function. transit-amplifying cells and surviving differentiated cells can temporarily conceal a loss of long-term renewal. Conversely, if output continues beyond their expected persistence and previously unlabelled cells restore long-lived clones, genuine compensation is likely. Repeated observation should therefore quantify target-cell depletion, proliferation, crypt survival, lineage composition and the re-emergence of Lgr5 expression throughout treatment and recovery.

Interpretation also depends on whether reserve cells form a permanently distinct hierarchy or are recruited from existing descendants. Expression of a proposed reserve marker does not prove that it exclusively labels a quiescent stem-cell population. Drivers can label several states, marker expression can change after injury, and apparent populations can overlap. An ablation-induced contribution from a marker-labelled cell is evidence of regenerative potential in that labelled lineage; it need not reveal its normal developmental position. Labelling before injury and allowing the inducing reagent to clear are essential to avoid marking newly activated cells and mistaking them for the original source.

Committed descendants provide direct evidence for such flexibility. Enterocyte-lineage progenitors labelled through Alpi normally give short-lived absorptive descendants, yet after Lgr5-cell ablation they can produce persistent renewing lineages. ^[ref] This supports intestinal stem-cell plasticity rather than an absolutely one-way hierarchy. It should not be generalized to every mature cell on a villus: a progenitor already biased toward an absorptive fate and a terminally mature enterocyte are different starting populations. Clonal persistence and renewed multilineage output are stronger endpoints than transient expression of one stem-cell marker.

Further work connected recovery of the ablated intestinal stem-cell compartment to Ascl2-dependent dedifferentiation of absorptive and secretory precursors. ^[ref] Regenerative cells can initiate the returning programme before the full usual marker combination is restored. This makes stemness a context-dependent functional state as well as a useful marker-defined category. It also yields a testable limit to compensation: if a required reprogramming regulator is disabled, the presence of alternative surviving cells need not be sufficient for recovery. Targeted perturbation should be assessed alongside precursor survival so that failure to reprogramme is not confused with removal of the proposed source.

Dispensability changes markedly when another injury removes or disables the compensating population. Combining Lgr5-cell depletion with radiation-induced damage caused severe crypt loss and failure of robust regeneration, unlike the relatively preserved homeostasis after depletion alone. ^[ref] This demonstrates conditional necessity in the tested injury regime. It does not create a contradiction with compensation under ordinary maintenance: the two interventions alter different components of the regenerative system. Radiation affects multiple epithelial and niche populations, and its timing relative to ablation and recovery is therefore part of the explanation rather than a minor technical detail.

A factorial experiment makes that logic explicit. Compare control, Lgr5-cell depletion alone, radiation alone, and the combination, with matched ages, intestinal regions and observation times. Include receptor-negative animals receiving toxin, receptor-positive untreated controls, and independent confirmation of cell removal rather than relying solely on loss of the fluorescent reporter. Measure crypt number and clonogenic recovery, epithelial composition, apoptosis, inflammatory or stromal damage and longer-term function. Evidence that surviving untargeted cells generate new stem-cell clones is required to identify the replacement mechanism; normal tissue appearance does not identify the source.

The duration of targeting is also important. A lineage that first lacks the marker but later adopts Lgr5 expression may become sensitive to continued toxin treatment. A pulse of ablation followed by repopulation and sustained elimination of the re-emerging state consequently test different hypotheses. Escaper cells with incomplete receptor expression or recombination can expand after treatment and mimic recruitment from another lineage. Pre-existing lineage labels, spatial imaging and independent ablation strategies help distinguish rare survivors from true conversion, while acknowledging that every strategy can perturb the niche itself.

Finally, removing Lgr5-expressing cells is not equivalent to deleting the Lgr5 gene. The former removes entire cells, including their other molecular functions; the latter changes a receptor while leaving the cells and possible compensating pathways in place. Likewise, demonstrating organoid growth under supplied matrix and growth factors establishes competence under those conditions, not niche independence in vivo. Normal renewal, replacement capacity and receptor requirement must therefore remain separate conclusions.

The evidence supports a plastic, partly redundant renewal system: Lgr5-positive cells are major normal contributors, can be replaced under some maintenance conditions, and can become crucial when injury limits alternative sources. The scientifically useful claim is conditional dispensability of a defined population under a defined protocol, not general irrelevance of those cells or the stem-cell state they exemplify.

Quantitative lineage tracing shifted the interpretation of squamous renewal from a necessarily rigid stem-cell hierarchy toward population-level balance, while live-cell imaging and injury experiments revealed local coordination and context-dependent plasticity. The resulting picture is neither that every basal cell is identical nor that one universal hierarchy applies to every anatomical site. Methods measure different properties, and their assumptions help explain apparently conflicting conclusions.

A classical model of stratified epithelium places long-lived stem cells above a finite sequence of transit-amplifying cells, whose descendants leave the basal compartment and differentiate. Spatial columns of epidermal cells and slow label dilution were interpreted in terms of epidermal proliferative units. Such observations are compatible with a hierarchy, but do not establish it uniquely. A label-retaining cell may divide slowly, be terminally differentiated, or retain label because of assay kinetics. Conversely, an actively cycling stem cell can lose a dilution-sensitive label rapidly. Clonogenicity after culture or transplantation measures potential in a perturbed environment rather than necessarily identifying the cells that sustain undamaged tissue.

Sparse, inducible permanent clonal lineage tracing allowed the descendants of individual basal cells to be followed without relying on label retention. Clone numbers, basal-cell contents and differentiated descendants could be quantified at multiple chase times and compared with explicit stochastic models. In mouse epidermis, such analysis supported a model in which one progenitor class generated both renewing and differentiating daughters, with balance achieved across the population rather than one obligatory asymmetric division for every stem cell. ^[ref] Clones disappeared while surviving clones expanded, even though the tissue remained stable. That pattern is not evidence that disappearing clones were necessarily a separate short-lived class.

The bookkeeping is informative. Suppose a proliferative cell divides to give two proliferative daughters with probability $r$, one proliferative and one differentiating daughter with probability $1-2r$, and two differentiating daughters with probability $r$, where $0\le r\le 1/2$. The expected number of proliferative daughters is:Thus the proliferative population can maintain itself even when individual divisions have different outcomes. In a simplified critical branching process with division rate $\lambda$, the effective rates of clone-size increase and decrease are both $\lambda r$ per proliferative cell. Starting from one such cell:The product remains one: increasing mean size among surviving clones can accompany unchanged expected labelled cell number across all initial clones. These formulae illustrate survivor conditioning; actual tissue geometry, noncycling basal cells, finite compartments and local interactions can require a different quantitative model.

Work on mouse oesophageal epithelium combined label-retention assays with lineage tracing and found that a single proliferative population could account for maintenance. After wounding, its outcomes became biased toward producing proliferating daughters, then returned toward balance after repair. ^[ref] Changing the division rate and changing the probability of daughter fates are different responses. More divisions with unchanged balance can accelerate replacement without expanding the renewing pool; biased outcomes can expand that pool. Neither observation alone requires conversion of a terminally differentiated cell into a stem cell.

Evidence for heterogeneity also remained important. Marker-selected tracing and proliferation analysis in mouse epidermis supported distinct slow-cycling stem and committed progenitor compartments. ^[ref] Such results should not be dismissed simply because a single-progenitor model fits another dataset. Anatomical site, promoter expression, induction dose, chase duration and which cells are scored can change the sampled population. A driver that preferentially labels a slow-cycling subset and a broadly induced driver need not produce the same clone distribution. Models should be compared against joint measurements of clone survival, cell cycle kinetics and labelled differentiated output rather than one convenient summary statistic.

Live intravital imaging added information that destructive sampling cannot supply. Tracking the same cells shows which event precedes which: division, loss of basal contact, movement into a suprabasal layer, or neighbour expansion. In adult mouse epidermis, local differentiation was followed by neighbour expansion and compensatory cell cycle progression, supporting a mechanism in which cell loss locally stimulates self-renewal. ^[ref] Balanced stochastic clone statistics therefore need not mean that cells make independent random decisions insulated from their neighbours. A spatially coordinated system can generate population-level fate balance and apparent randomness at the level of individual retrospective clones.

Modern molecular methods refine, but do not replace, those functional tests. single-cell RNA sequencing identifies heterogeneous molecular states and pathway activity; spatial measurements locate them relative to basement membrane, follicles or wounds. A trajectory inferred from transcriptomes is not a directly observed lineage, and an intermediate expression profile can reflect a transient response rather than a cell reversing fate. Combining molecular profiling with permanent labels, repeated imaging and appropriately timed perturbations distinguishes state similarity, ancestry and causal requirement. cell cycle state and injury-associated inflammation also need to be separated from a genuinely distinct renewing population.

Direct evidence for cell fate plasticity requires more than changing proliferation within an existing progenitor class. Pre-injury labelling of GATA6-expressing differentiated sebaceous-duct cells showed that their descendants could move into wounded interfollicular epidermis, regain basal renewing properties and produce a broader range of epidermal descendants. Long-term tracing and live observations supported dedifferentiation under the wound conditions. ^[ref] The key comparison is the fate of the same pre-labelled population in undamaged and damaged tissue. It is not sufficient to find Gata6-lineage fluorescence in a cell that has just begun expressing the marker after injury.

Several controls make such a claim persuasive. Verify the initial labelled cell identities before damage; allow the inducer to clear; exclude rare pre-labelled stem cells or reporter leakage; and demonstrate sustained renewal rather than transient basal residence. Imaging a labelled cell's transition and showing its later functional output is stronger than a static double-positive image. Exclude cell fusion and selective expansion of an unrecognized initial subpopulation where relevant. Perturbing a proposed reprogramming regulator should preserve source-cell viability, since losing the source is not the same as preventing its identity change.

The general conclusion is a flexible hierarchy of evidence. Label retention measures division history, clonal tracing measures descendant output, live-cell imaging measures event order and local interactions, and molecular profiling measures state. Together they support dynamic population self-renewal, site-dependent heterogeneity and injury-induced epithelial plasticity, while leaving normal maintenance distinct from regenerative potential. Claims about one mouse skin region or oesophagus should be tested independently before being generalized to every squamous tissue or to humans.

Intestinal development constructs a patterned renewing organ; intestinal homeostasis continually replaces its cells while preserving that organization. Both depend on reciprocal signalling between endoderm-derived epithelium and mesenchyme, but they solve different problems. Development expands and regionalizes the tissue, establishes architecture and produces its first mature cell types. Adult tissue homeostasis balances cell production, cell differentiation, movement and loss within an already established architecture. The mammalian small intestine provides the main comparison; its villi and crypts should not be indiscriminately attributed to the colon or to all vertebrates.

Early intestinal development begins with a broadly proliferative epithelial tube whose regional identity is established in its embryonic context. Factors including CDX2 help impose intestinal identity, while local signals distinguish the future small intestine and colon. Growth is coordinated with the formation of smooth muscle, connective tissue, the enteric nervous system and vasculature. The emergence of intestinal villi transforms a relatively simple luminal surface into an absorptive one. In mouse, epithelial Hedgehog signalling promotes underlying mesenchymal clusters, and BMP signalling helps space those clusters. In explants, increased BMP activity suppresses clusters whereas BMP inhibition produces merged clusters and abnormal villus patterns. This supports a role in pattern generation, not simply in the terminal differentiation of enterocytes.^[ref]

The mechanics and signalling must be distinguished across species. In chick, sequential smooth muscle differentiation constrains growth, generating ridges, zigzags and villi through buckling. In mouse, patterned mesenchymal clusters arise before equivalent surface deformation, so the chick sequence is not a general account of mammalian villus initiation. The common principle is reciprocal communication between layers; the ordering of mechanical and chemical patterning differs. In development, therefore, an abnormal villus pattern could arise from defective mesenchymal organization, epithelial growth or mechanical coupling, even if the final epithelial cell differentiation markers are present.

As villi emerge, proliferative cells become concentrated in intervillus regions, and intestinal crypts develop chiefly around the perinatal and postnatal transition in mouse. The fetal proliferative epithelium is consequently not simply a miniature adult crypt. Paneth cells and other components of the mature niche also appear on their own developmental schedules. Demonstrating an adult stem-cell marker in an embryonic cell would not alone establish that the embryonic lineage hierarchy or niche requirements are identical to the adult ones.

In adult small-intestinal tissue homeostasis, cycling Lgr5 positive intestinal stem cells at crypt bases generate renewed stem cells and transit-amplifying cells. Descendants differentiate into absorptive enterocytes and secretory populations including goblet cells, enteroendocrine cells, tuft cells and Paneth cells. Most differentiated descendants move toward the villus tip and are shed, whereas Paneth cells occupy the crypt base. lineage tracing from the Lgr5 locus generated persistent contributions to all epithelial lineages, providing functional evidence for self-renewal and multipotency rather than relying on marker expression alone.^[ref]

The adult niche spatially restricts developmental pathways. High local Wnt signalling and R-spondin support crypt stemness and growth, while BMP signalling restrains crypt-like programmes outside their appropriate domain. Notch signalling favours absorptive over secretory lineage allocation partly by opposing ATOH1-dependent secretory specification. Thus a single pathway can control both population maintenance and cell composition: stimulating proliferation is not sufficient if the resulting cell differentiation balance is wrong. Stromal signals are essential in vivo, and Paneth cells provide additional local support in small intestine; the colon maintains stem cells without a small-intestinal Paneth-cell arrangement. Niche dependence cannot therefore be equated with dependence on one invariant supporting cell type.

The adult organ is dynamically stable rather than cellularly static. A stem-cell clone can expand while neighbouring stem-cell clones disappear through neutral drift, with the total compartment maintained.^[ref] At the organ level, sustained excess production generates expansion or neoplasia; excess loss causes barrier failure. Development deliberately changes total cell number, surface area and proportions over time, whereas adult maintenance constrains their long-term averages. Nevertheless, adult tissue homeostasis remains responsive to feeding, microbes, immune signals and injury, and is not a completely fixed endpoint.

Experimental models expose both continuity and differences. A single sorted Lgr5 positive cell can produce a self-renewing intestinal organoid containing organized differentiated progeny in a suitable matrix and supplied growth factors. This establishes epithelial self-organization under defined conditions, not niche independence in the absence of extracellular signals: the medium replaces important niche functions.^[ref] Embryonic explants retain the mesenchyme needed to study villus patterning, while adult intestinal organoids are especially useful for stem-cell maintenance and lineage allocation. Neither alone reproduces an intact organ's circulation, innervation, immune environment and longitudinal regionalization.

Finally, injury reveals an important bridge between development and maintenance. cell fate plasticity can restore missing stem cells, so the normal adult lineage flow is not an irreversible restriction of all descendants. Committed progenitor cells can recover stem-cell function under particular injury conditions, but this does not establish that all mature villus cells routinely do so. A decisive comparison uses stage-specific lineage tracing, matched marker analysis and timed pathway perturbation, measuring architecture and functional output as well as cell proliferation. Development and adult renewal reuse molecular machinery while differing in tissue geometry, developmental competence and the direction of net population change.

Epithelial cell fate plasticity is a context-dependent change in developmental potential or differentiated identity. It includes dedifferentiation toward a progenitor cell state, transdifferentiation between differentiated identities, and reversible intermediate states. It is distinct from selecting a pre-existing rare stem cell, and from ordinary progression down a lineage. epithelial-mesenchymal plasticity is one important form, but changing epithelial subtype without losing epithelial organization is also cell fate plasticity.

The strongest physiological rationale is that a tissue needs both stable specialization and reserve routes for replacement. During ordinary adult tissue homeostasis, a stem-cell hierarchy can efficiently supply predictable cell types. After injury removes a component of that hierarchy, local signals and newly available stem-cell niche space may permit a committed descendant to reacquire self-renewal. In mouse intestine, Alpi marked enterocyte-lineage progenitor cells normally generate short-lived absorptive descendants. After targeted ablation of Lgr5 positive intestinal stem cells, labelled progenitor cells can generate long-lived crypt-villus lineages with renewed stem-cell output. Comparing the same labelled population before and after ablation distinguishes injury-dependent cell fate plasticity from its normal fate. The experiment concerns progenitor cells in the enterocyte lineage; it should not be generalized to every terminally mature villus enterocyte.^[ref]

A complementary model is the mouse airway. Genetic depletion of basal stem cells, combined with prior lineage tracing of luminal secretory cells, revealed secretory-cell descendants that acquired basal-cell properties and sustained subsequent epithelial production. Experiments with isolated cells and cocultures further showed that contact with basal cells inhibits this conversion. cell fate plasticity is therefore regulated by the tissue environment, not simply an intrinsic capacity unmasked whenever a marker changes. Its interpretation requires controls for residual basal cells and for whether the secretory-lineage driver labelled basal cells before injury.^[ref]

Development provides additional contexts. Embryonic epithelia can undergo epithelial-to-mesenchymal transition during processes such as gastrulation, and mesenchymal-to-epithelial transition can subsequently assemble epithelial structures. These are regulated changes in adhesion, cell polarity, motility and gene expression, rather than a simple binary switch read from E-cadherin alone. In wound repair, transient relaxation of epithelial organization can facilitate migration while retaining intercellular contacts. A partially migratory repair state need not entail a complete mesenchymal conversion or a permanent change of lineage. Following wound closure, restoration of barrier function and polarized architecture is as important as the initial ability to move.

The most convincing experimental design labels a defined starting population irreversibly before the inducing event, allows the inducer to clear, then follows labelled descendants through the transition. Check immediate labelling specificity, include no-inducer and uninjured controls, quantify labelling efficiency and rule out ectopic driver activation after injury. Demonstrate the new state with multiple markers, morphology and function, and persistence after the inducing signal is removed. Serial epithelial production or a second injury challenge tests stable self-renewal; a transient appearance of a basal marker does not. Sparse labelling and continuous live-cell imaging help distinguish conversion from contamination, cell fusion or selective expansion of a rare initially unrecognized progenitor cell.

single-cell RNA sequencing can identify intermediate cell states and candidate regulators, but inferred trajectories are not lineage histories. Combine it with genetic barcodes, spatial localization and timed perturbation of candidate transcription factors or niche signals. Organoids offer defined media, prospective cell isolation and manipulation of matrix stiffness. A sorted population's ability to make a structure in culture establishes potential under those conditions; dissociation and a permissive medium may induce a capacity rarely used in vivo. Compare culture results with intact-tissue fate mapping before claiming a normal physiological contribution.

The evolutionary argument is a trade-off, rather than a claim that every plastic response is an adaptation. Conditional access to alternative cell fates could buffer environmental injury and permit repair without maintaining a separate reserve stem-cell pool for every possible lesion. Conserved signalling modules can also be redeployed in new developmental contexts. These advantages must be weighed against loss of specialized function, energetic costs and the danger of inappropriate persistent growth. Comparative experiments should ask whether homologous lineages undergo similar transitions under comparable injuries; shared expression of a few regulators is insufficient to prove that an ancestral cell fate plasticity programme has been conserved. At the tissue level, cell fate plasticity supplies alternative states on which selection can act, but it does not itself establish heritable evolutionary change.

Clinically, controlled cell fate plasticity may improve epithelial repair, provide transplantable cells and make patient-derived disease models. The same capacity can undermine treatment: a tumour may switch to a less drug-sensitive lineage or regenerate a stem-like population after therapy. In carcinoma, epithelial-mesenchymal plasticity can contribute to invasion and treatment resistance, but neither a single EMT marker nor its absence establishes the mechanism of metastasis. In a lineage-traced mouse lung-cancer model, the tested EMT programme was dispensable for lung metastasis while contributing to chemoresistance; the conclusion is specific to that model and reporter coverage.^[ref] The useful clinical aim is therefore a defined, reversible transition that restores function, with evidence that it does not leave a persistently proliferative or malignant population.